Citation: Yelena Ogneva-Himmelberger, Tyler Dahlberg, Kristen Kelly, Tiffany A. Moore Simas. Using Geographic Information Science to Explore Associations between Air Pollution, Environmental Amenities, and Preterm Births[J]. AIMS Public Health, 2015, 2(3): 469-486. doi: 10.3934/publichealth.2015.3.469
[1] | Yu Li, Zhehui Luo, Claudia Holzman, Hui Liu, Claire E. Margerison . Paternal race/ethnicity and risk of adverse birth outcomes in the United States, 1989–2013. AIMS Public Health, 2018, 5(3): 312-323. doi: 10.3934/publichealth.2018.3.312 |
[2] | Wei Tu, Jun Tu, Stuart Tedders . A Multilevel Analysis of Neighborhood Socioeconomic Effect on Preterm Births in Georgia, USA. AIMS Public Health, 2015, 2(4): 638-654. doi: 10.3934/publichealth.2015.4.638 |
[3] | Rolf Nieder, Dinesh K. Benbi . Integrated review of the nexus between toxic elements in the environment and human health. AIMS Public Health, 2022, 9(4): 758-789. doi: 10.3934/publichealth.2022052 |
[4] | Dreaves Hilary A . How Health Impact Assessments (HIAs) Help Us to Select the Public Health Policies Most Likely to Maximise Health Gain, on the Basis of Best Public Health Science. AIMS Public Health, 2016, 3(2): 235-241. doi: 10.3934/publichealth.2016.2.235 |
[5] | Ioan Stelian Bocşan, Irina Brumboiu, Tudor Călinici, Mariana Vlad, Cecilia Roman, Ioana Brie, Mihaela Lucia Ponta . G.I.S. Surveillance of Chronic Non-occupational Exposure to Heavy Metals as Oncogenic Risk. AIMS Public Health, 2016, 3(1): 54-64. doi: 10.3934/publichealth.2016.1.54 |
[6] | Alfred M Levine, Donna B Gerstle . Female breast cancer mortality in relation to puberty on Staten Island, New York. AIMS Public Health, 2020, 7(2): 344-353. doi: 10.3934/publichealth.2020029 |
[7] | Marte K.R. Kjøllesdal, Gerd Holmboe-Ottesen . Dietary Patterns and Birth Weight—a Review. AIMS Public Health, 2014, 1(4): 211-225. doi: 10.3934/Publichealth.2014.4.211 |
[8] | Carmen Giurgescu, Lara Fahmy, Jaime Slaughter-Acey, Alexandra Nowak, Cleopatra Caldwell, Dawn P Misra . Can support from the father of the baby buffer the adverse effects of depressive symptoms on risk of preterm birth in Black families?. AIMS Public Health, 2018, 5(1): 89-98. doi: 10.3934/publichealth.2018.1.89 |
[9] | Chakib Nejjari, Abdelghafour Marfak, Ahmed Rguig, Abderrahmane Maaroufi, Ihssane El Marouani, Abderrafii El Haloui, Bouchra El Johra, Rachid Ouahabi, Rachid Moulki, Amina Idrissi Azami, Youness El Achhab . Ambient air pollution and emergency department visits among children and adults in Casablanca, Morocco. AIMS Public Health, 2021, 8(2): 285-302. doi: 10.3934/publichealth.2021022 |
[10] | Susanne Klawetter, Jennifer C. Greenfield, Stephanie Rachel Speer, Kyria Brown, Sunah S. Hwang . An integrative review: maternal engagement in the neonatal intensive care unit and health outcomes for U.S.-born preterm infants and their parents. AIMS Public Health, 2019, 6(2): 160-183. doi: 10.3934/publichealth.2019.2.160 |
With the growing understanding of the importance of a proper magnesium homeostasis during pregnancy, an increasing number of studies have used magnesium for treatment or prevention of different pathological conditions in pregnancy. The aims of the review is to describe the major studies performed on treatment with magnesium in pregnancy related complications. The studies reviewed were collected from a previous Cochrane review with differences in the criteria for the evaluation of the relevance of the studies [1].
Based in the knowledge regarding the pivotal role of magnesium in enzyme systems, muscular function and bone calcium homeostasis [2], a large number of studies has been reported on the treatment of different pathological conditions with magnesium. Regarding pregnancy, the treatment of pre-eclampsia and eclampsia with MgSO4 is an established procedure. The treatment is initiated on suspicion of eclampsia or when the symptoms are fully established. It comprises an intravenous injection (usually 4-6 g), followed by sometimes followed by a maintenance dose given intravenously or intramuscularly. Side effects are nausea, flushing, and muscle weakness. A Cochrane review evaluated 13 studies, one of which comprised 10^141 women [3]. In general the treatment was found to be efficient in about half the cases. Similar findings were reported in a review comprising studies from Bangladesh, India, Pakistan, Nigeria, and the UK [4].
The initial concept for introducing MgSO4 in the treatment of eclampsia and pre-eclampsia was as an anticonvulsive agent, as the anti-cramp properties of this agent (Epsom salt) have been known since the 1600th century. Recent data suggest that the effect may be mediated through prevention of oxidative damage through interactions with alkyl radicals [5]. A study on pregnant women from Sub-Saharan Africa evaluated the role of MgSO4 treatment and increased use of transfers to hospitals [6]. About 17000 maternal deaths were associated with PE/E. A more extensive use of MgSO4 would have prevented 610 deaths.
In addition to treatment of pre-eclampsia and eclampsia, MgSO4 has also been used in attempts to protect the children from neurological disorders as reviewed in two meta-analysis [7,8]. One study found a reduction of hypotension treatment and invasive mechanical ventilation in pre-term infants treated with MgSO4 [9].
In addition to treating an established or almost established disease, several studies have attempted to avoid the development of disease by giving magnesium as a supplement during the whole pregnancy. The rationale for this is the many reports that describe an insufficient supply of magnesium in the food intake among pregnant women [10,11,12].
The conductance and interpretation of results from such magnesium supplementation studies in populations may be influenced by a number of methodological problems [13]. An effect of the supplementation can only be expected in a risk group i.e. persons with a magnesium deficiency. The proportion of such risk persons in the population studied or differences in that proportion between different population groups would thus influence the results. Evaluating the effect in the whole population studied without identifying the risk group might thus lead to a false conclusion concerning the absence of an effect.
The therapeutic range is of importance. Some earlier studies used low doses of magnesium in the supplementation—128 mg [14]. Another study administered magnesium (100 mg) also to the control group, yielding a therapeutic range of 270 mg [15]. This is relatively low in comparison to the 300-400 mg doses usually used. The lower dose administered to the control group—100 mg— might also have been sufficient to reduce a negative effect induced by magnesium deficiency.
Several studies have investigated the possibility to prevent the pregnancy induced high increase in blood pressure, including pre-eclampsia and eclampsia, during pregnancy by giving a supplementation of magnesium throughout pregnancy. In a double blind, randomised controlled (DBRC) study in Denmark, 50 women with a pregnancy induced hypertension were given intravenous magnesium chloride for two days and then an oral supply of magnesium hydroxide till the end of the pregnancy [16]. In the supplemented group, mean atrial blood pressure was significantly lower from day three of supplementation till delivery.
In a DBRC study from China, 51 pregnant women were given 175 mg magnesium gluconate daily [17]. In the supplemented group 4% of the women developed hypertension as compared to 16% in the placebo group. In a partial DBRC study from Angola 150 pregnant women were given primrose and fish oil, magnesium oxide or placebo [18]. In the magnesium group there were two women with high blood pressure (systolic >30 and/or diastolic > 15 mm Hg) as compared to 13 in the untreated group.
In a DBRC study from Sweden, prima-para subjects were given 300 mg magnesium as a citrate salt or placebo from around pregnancy week 25 throughout the pregnancy [19]. The changes in diastolic blood pressure at different times during the pregnancy in relation to the value at 12 weeks were evaluated and magnesium sensitive transporter gene (MgTG) expressions were measured [20]. The percentage of women with an increase of ≥15 mm Hg in diastolic blood pressure was significantly lower in the magnesium supplemented group. Among those with an increase in urinary magnesium excretion during pregnancy, reflecting the increased intake, there was a decrease in the diastolic blood pressure (corr coeff -0.438, p = 0.005). Systolic and diastolic blood pressures at week 37 (excluding the magnesium treated group) were significantly related to the expression of the MgTGs SLC41A1 and SLC41A3. In week 12 as well as in week 37, the expression of TRPM6 was significantly higher as compared to a group of non-pregnant subjects (p = 0.007). In the placebo group the expression of gene TRPM6 was significantly higher among those with an increase in diastolic blood pressure ≥15 mm Hg (0.84/0.07 vs. 0.64/0.04, p = 0.013). There was also an inverse relationship between the expression of TRPM6 and the urinary excretion of magnesium (corr coeff -0.596, p = 0.015).
One study could not demonstrate an effect of magnesium- aspartate hydrochloride on high blood pressure [15]. This was not, however, a double blind study but administered two dose levels of magnesium—100 mg and 365 mg. It is likely that the narrow therapeutic range (265 mg) or the absence of a non-intervention group, reflecting basic conditions, decreased the sensitivity of the study. Another study could also not demonstrate an effect after administration of 360 mg magnesium hydrochloride throughout pregnancy [21]. Blood pressure data were, however, only presented for the whole group. The statistically significant differences in birth weight etc (see below) were only present when patients not taking their magnesium tablets properly were excluded. Blood pressure data from this group were not reported.
In summary, four studies from four different countries demonstrate that the supplementation with magnesium during pregnancy reduces the risk of pregnancy induced high blood pressure
There are several studies where the effect of magnesium supplementation on other pregnancy complications than high blood pressure have been studied.
In one DBRC study with 985 pregnant women, the supply of 360 mg magnesium aspartate significantly reduced the frequency of premature deliveries (< 258 days), and the number of children with a birth weight < 500 g [22]. The incidence of pre-eclampsia was significantly lower in the magnesium treated group. Another DBRC supplementation study comprised 568 pregnant women, allocated magnesium hydrochloride (365 mg) or placebo according to even/odd numbers of birth date [23]. The number of days spent in hospital due to pregnancy complications was 533 days in the magnesium group and 887 days in the placebo group. The number of women with pre-term labour, pre-term deliveries, and incomplete cervix closure was significantly lower in the magnesium group. The effect on pre-eclampsia could not be evaluated due to the small number of subjects with this complication.
Contradictory findings were reported in a DBRC study on 374 pregnant women [15]. They received 375 mg magnesium/day in terms of magnesium-aspartate hydrochloride. No significant differences were found between the magnesium and placebo groups regarding blood pressure, foetal growth retardation, pre-eclampsia, preterm labour, birth weight, gestational age at delivery, or number of infants admitted to a special care hospital unit. The absence of any of these effects, quite in contrast to the previously cited study, could be due to an erroneous study design. The placebo group received a vitamin supplement containing 100 mg magnesium. Even this small dose might have influenced the investigated parameters, decreasing the difference between the magnesium high dose and the magnesium low dose groups to non-significant levels.
The same endpoints as in the above two studies were investigated in an investigation in Italy [23]. 100 pregnant women participated in this DBRC study where 360 mg magnesium was administered daily. There were fewer hospitalisation days for the mother in the supplemented group as well as fewer premature births, and less underweight (< 2500 g) children.
Similar findings were reported in a DBRC study on 240 magnesium citrate supplemented women and 250 controls [24]. The supplemented group had a significantly lower number of hospitalisation days for mothers due to threats of preterm labour, and higher birth weight for the babies. There was a tendency to lower rates of preterm labour and low birth weight (< 2500 g) in the supplemented group.
In a small study on pregnant women, selected for risk of pre-mature labour, 22 women received 216 mg magnesium gluconate [25]. There were no differences in terms of preterm labour, gestational age at delivery or mean birth weights. There was no magnesium serum level increase in the supplemented group among the five women with preterm labour.
Hypoxic, ischaemic encephalopathy (HIE) was studied in a sample of 4494 women with a low magnesium intake in food [26]. The supplementation was 64 mg magnesium/day, leading to a significantly higher level of red blood cell content of magnesium at delivery (1.75 vs 1.68 mmol/L). There was a significantly lower number of stillbirths in the magnesium supplemented group. There were no differences in gestational hypertension, premature onset of labour, or duration of pregnancy. There was a non-significant trend to a lower incidence of HIE in the magnesium treated group (15 vs 22 babies). If the supplemented and control groups were amalgamated, women with a red blood cell magnesium level below the median, had a sevenfold risk of having a baby with HIE. The authors concluded that due to the low incidence of HIE the study was statistically underpowered. The dose of magnesium in this study was quite low.
Leg cramps is a common symptom in magnesium deficiency and they become more prevalent during pregnancy. One study comprised 74 pregnant women with leg cramps [27]. The supplementation in this DBPC study was 360 mg magnesium as citrate or lactate. There was a significantly larger reduction of subjectively experienced stress due to leg cramps in the supplemented group. Persisting symptoms the days after night cramps were also lower.
It is beyond doubt that magnesium plays an important role for the functioning of many different organs in the body, particularly muscles [2]. Regarding supplementation with magnesium during pregnancy to decrease the incidence of pregnancy complications, the picture is less clear. For all effects studied, there are positive as well as negative outcomes. The Cochrane report examined the different studies and classified some of those showing a beneficial effect as “low quality studies” [1]. Applying the latest scientific paradigms concerning study designs as in that review, will obviously discard older studies, performed according to principles used at that time although the data may be valid. On the other hand it is important to perform a quality assurance, both regarding conclusions how to deal with the supplementation problem today and as a background for future studies, There are, however, some basic errors in the Cochrane evaluation. One study was discarded as low quality as the assignment of supplementation/placebo was made according to the mothers’ birthday (odd-even) [21]. Even if this criterion does not fulfil the definition of DBRC as used today, the judgement is erroneous from a biological point of view. Birth dates, related to days, could not induce an error in relation to a biological effect. Furthermore, a study classified as good quality [15] administered magnesium also to the control group which is not a correct DBRC design and might have introduced dosage errors as discussed above.
Apart from the strict scientific judgement of the studies as in Cochrane [1], there must also be a personalised interpretation of available data and the risk related to supplementation, weighing information regarding possible benefits. In contrast to medication e.g. with aspirin which has been tried in pre-eclampsia [28], magnesium is a natural substance and completely harmless except for occasional cases of diarrhoea. This implies that a decision to prescribe supplementation with magnesium should also take into account data from studies which may not be perfect according to modern standards. One should also weigh the tremendous savings that would result in terms of suffering of children and mothers as well as the costs for caretaking and treatment of PE and E. This being said, there is obviously a need for further studies, particularly in risk groups with high incidences of PE and E. With the data available and the lack of a risk supplementing with magnesium, one could, however, question whether a double-blind design in such studies is ethically correct.
From a practical point of view, the absence of a consensus regarding magnesium treatment should not hinder the physician or maternal health care responsible to suggest a supplementation with magnesium, particularly to women with early symptoms such as leg cramps, oedema, and blurred vision.
The author declares no conflict of interest in this article.
[1] | CDC (2013) CDC Features-National Prematurity Awareness Month. Available from: http://www.cdc.gov/features/prematurebirth/. |
[2] | CDC (2013) FASTSTATS - Birthweight. Available from: http://www.cdc.gov/nchs/fastats/birthweight.htm. |
[3] |
Fan RG, Portuguez MW, Nunes ML (2013) Cognition, behavior and social competence of preterm low birth weight children at school age. Clinics (Sao Paulo) 68: 915-921. doi: 10.6061/clinics/2013(07)05
![]() |
[4] |
Hutchinson EA, De Luca CR, Doyle LW, et al. (2013) School-age outcomes of extremely preterm or extremely low birth weight children. Pediatrics 131: e1053-1061. doi: 10.1542/peds.2012-2311
![]() |
[5] |
DeFranco E, Lian M, Muglia L, et al. (2008) Area-level poverty and preterm birth risk: a population-based multilevel analysis. BMC Public Health 8: 316. doi: 10.1186/1471-2458-8-316
![]() |
[6] | Anthopolos R, James SA, Gelfand AE, et al. (2011) A spatial measure of neighborhood level racial isolation applied to low birthweight, preterm birth, and birthweight in North Carolina. SSE 2: 235-246. |
[7] |
Bloch JR (2011) Using Geographical Information Systems to Explore Disparities in Preterm Birth Rates Among Foreign-born and U.S.-born Black Mothers. J Obst Gynecol Neonat Nurs 40: 544-554. doi: 10.1111/j.1552-6909.2011.01273.x
![]() |
[8] | Herrick H (1996) The association of poverty and residence in predominantly black neighborhoods with the occurrence of preterm births among black women: a case-control study of three North Carolina metropolitan areas: Citeseer. Available from: www.schs.state.nc.us/schs/pdf/CHES99.pdf . |
[9] | Martin JA, Hamilton BE, Osterman MJK, et al. (2013). Preterm Births — United States, 2006 and 2010. MMWR, 63: 136-138. |
[10] | Brender JD, Maantay JA, Chakraborty J (2011) Residential proximity to environmental hazards and adverse health outcomes. Am J Publ H 101 Suppl 1: S37-52. |
[11] | Wu J, Wilhelm M, Chung J, et al. (2011) Comparing exposure assessment methods for traffic-related air pollution in an adverse pregnancy outcome study. Environ Res 111: 685-692. |
[12] |
Brauer M, Lencar C, Tamburic L, et al. (2008) A cohort study of traffic-related air pollution impacts on birth outcomes. Environ H Perspect 116: 680-686. doi: 10.1289/ehp.10952
![]() |
[13] | Currie J, Neidell MJ, Schmieder J (2008) Air Pollution and Infant Health: Lessons from New Jersey. National Bureau of Economic Research, Working paper No. 14196. Available from: http://www.nber.org/papers/w14196. |
[14] |
Généreux M, Auger N, Goneau M, et al. (2008) Neighbourhood socioeconomic status, maternal education and adverse birth outcomes among mothers living near highways. J Epidemiol Commun H 62: 695-700. doi: 10.1136/jech.2007.066167
![]() |
[15] |
Ponce NA, Hoggatt KJ, Wilhelm M, et al. (2005) Preterm Birth: The Interaction of Traffic-related Air Pollution with Economic Hardship in Los Angeles Neighborhoods. Am J Epidemiol 162: 140-148. doi: 10.1093/aje/kwi173
![]() |
[16] | Ritz B, Wilhelm M (2008) Ambient air pollution and adverse birth outcomes: methodologic issues in an emerging field. Basic Clin Pharmacol Toxicol102: 182-190. |
[17] |
Yorifuji T, Naruse H, Kashima S, et al. (2013) Residential proximity to major roads and adverse birth outcomes: a hospital-based study. Environ H 12: 34. doi: 10.1186/1476-069X-12-34
![]() |
[18] |
Miranda ML, Edwards SE, Chang HH, et al. (2013) Proximity to roadways and pregnancy outcomes. J Expos Sci Environ Epidemiol 23: 32-38. doi: 10.1038/jes.2012.78
![]() |
[19] | Zeka A, Melly SJ, Schwartz J (2008) The effects of socioeconomic status and indices of physical environment on reduced birth weight and preterm births in Eastern Massachusetts. Environ H 7: 60. |
[20] | Lee ACK, Maheswaran R (2010) The health benefits of urban green spaces: a review of the evidence. J Publ H 33: 212-222. |
[21] | Donovan GH, Michael YL, Butry DT, et al. (2011) Urban trees and the risk of poor birth outcomes. H Plac 17: 390-393. |
[22] |
Laraia B (2004) Proximity of supermarkets is positively associated with diet quality index for pregnancy. Prev Med 39: 869-875. doi: 10.1016/j.ypmed.2004.03.018
![]() |
[23] |
Byrnes J, Mahoney R, Quaintance C, et al. (2015) Spatial and temporal patterns in preterm birth in the United States. Pediatr Res 77: 836-844. doi: 10.1038/pr.2015.55
![]() |
[24] | Markley S, Tu W (2015) Regional and racial disparity of preterm birth prevalence in Georgia, 1995-2012. P Appli Geogr 1: 168-175. |
[25] | Meng G, Hall GB, Thompson ME, et al. (2013) Spatial and environmental impacts on adverse birth outcomes in Ontario. Can Geogr / Le Géogr Can 57: 154-172. |
[26] | South AP, Jones DE, Hall ES, et al. (2011) Spatial analysis of preterm birth demonstrates opportunities for targeted intervention. Matern Child H J 16: 470-478. |
[27] |
Miranda ML, Maxson P, Edwards S (2009) Environmental contributions to disparities in pregnancy outcomes. Epidemi Reviews 31: 67-83. doi: 10.1093/epirev/mxp011
![]() |
[28] | Census Bureau (2014) Worcester Quick Facts. Available from: http://quickfacts.census.gov/qfd/states/25/2582000.html. |
[29] | City of Worcester M (2014) History, Trivia, Vital Stats & More! Available from: http://www.worcesterma.gov/city-clerk/history |
[30] | Worcester Regional Research Bureau (2013) Worcester's Demographic Trends: 2010 Census. Worcester, MA. Available from: http://www.wrrb.org/reports/2013/02/worcesters-demographic-trends-2010-census/. |
[31] | EPA (2014) Brownfields and Land Revitalization. Available from: http://www.epa.gov/brownfields/. |
[32] | EPA (2014) Toxic Release Inventory Fatsheet. Available from: http://www2.epa.gov/sites/production/files/documents/RY_2011_TRI_Factsheet.pdf . |
[33] | MassDOT (2009) Traffic Volume Counts. Available from: http://www.mhd.state.ma.us/downloads/trafficCounts/BOOK2009.ZIP. |
[34] | Spear M (1977) Worcester's Three-Deckers: Worcester Bicentennial Commission. |
[35] | Gibson C, Jung K (2006) Historical Census Statistics on the Foreign-Born Population. U.S. Census Bureau. Available from: https://www.census.gov/population/www/documentation/twps0081/twps0081.pdf . |
[36] | Martin JA, Osterman MJK (2013) Preterm Births — United States, 2006 and 2010. Morbi Mortali Wkly Report pp. 136-138. |
[37] | MassGIS (2014) 2010 U.S. Census - Environmental Justice Populations. Available from: http://www.mass.gov/anf/research-and-tech/it-serv-and-support/application-serv/office-of-geographic-information-massgis/datalayers/cen2010ej.html. |
[38] | MassGIS (2012) Massachusetts Department of Transportation (MassDOT) Roads. Available from: http://www.mass.gov/anf/research-and-tech/it-serv-and-support/application-serv/office-of-geographic-information-massgis/datalayers/eotroads.html . |
[39] | MassGIS (2014) Protected and Recreational OpenSpace. Available from: http://www.mass.gov/anf/research-and-tech/it-serv-and-support/application-serv/office-of-geographic-information-massgis/datalayers/osp.html . |
[40] | EPA (2013) Risk Screening Environmetal Indicators Methodology. Available from: http://www.epa.gov/opptintr/rsei/pubs/rsei_methodology_v2_3_2.pdf. |
[41] | Sicotte D, Swanson S (2007) Whose Risk in Philadelphia? Proximity to Unequally Hazardous Industrial Facilities. Soci Sci Q 88: 515-534. |
[42] | Williams MM (2010) Health risks from point sources of industrial air pollution: modeling toxicity and exposure. In: Chakraborty J, Bosman MM, editors. Spati Environ Injustice Am Metropolis: A Study of Tampa Bay,Florida. Amherst, NY: Cambria Press. pp. 145-151. |
[43] | Silverman BW (1986) Density Estimation for Statistics and Data Analysis. New York: Chapman and Hall. |
[44] | Barrett J (2009) Delivering New Data - Local Traffic Pollution and Pregnancy Outcomes. Environ H Perspect 117: A 505. |
[45] |
Malmqvist E, Rignell-Hydbom A, Tinnerberg H, et al. (2011) Maternal exposure to air pollution and birth outcomes. Environ H perspect 119: 553. doi: 10.1289/ehp.1002564
![]() |
[46] |
Rudra CB, Williams MA, Sheppard L, et al. (2011) Ambient carbon monoxide and fine particulate matter in relation to preeclampsia and preterm delivery in western Washington state. Environ H Perspect 119: 886. doi: 10.1289/ehp.1002947
![]() |
[47] | Wilhelm M, Ritz B (2003) Residential proximity to traffic and adverse birth outcomes in Los Angeles county, California, 1994-1996. Environ H Perspect 111: 207. |
[48] |
Wu J, Ren C, Delfino RJ, et al. (2009) Association between local traffic-generated air pollution and preeclampsia and preterm delivery in the south coast air basin of California. Environ H Perspect 117: 1773. doi: 10.1289/ehp.0800334
![]() |
[49] | Elliott P, Briggs D, Morris S, et al. (2001) Risk of adverse birth outcomes in populations living near landfill sites. BMJ: 323: 363. |
[50] | Levine N (2013) CrimeStat: A Spatial Statistics Program for the Analysis of Crime Incident Locations (v 4.0). Ned Levine & Associates, Houston, Texas, and the National Institute of Justice, Washington, D.C. |
[51] | Johnson L, Ratcliffe JH (2013) When Does a Drug Market Become a Drug Market? Finding the Boundaries of Illicit Event Concentrations. In: Leitner M, editor. Cri Mod Map Geo Tech: Springer. pp. 25-48. |
[52] |
Lucan SC, Maroko A, Shanker R, et al. (2011) Green Carts (Mobile Produce Vendors) in the Bronx—Optimally Positioned to Meet Neighborhood Fruit-and-Vegetable Needs? J Urban H 88: 977-981. doi: 10.1007/s11524-011-9593-2
![]() |
[53] |
Lai PC, Low CT, Wong M, et al. (2009) Spatial analysis of falls in an urban community of Hong Kong. Intern J H Geogr 8: 14. doi: 10.1186/1476-072X-8-14
![]() |
[54] | EPA (2014) Chromium compounds. Available from: http://www.epa.gov/ttn/atw/hlthef/chromium.html. |
1. | Severine Deguen, Nina Ahlers, Morgane Gilles, Arlette Danzon, Marion Carayol, Denis Zmirou-Navier, Wahida Kihal-Talantikite, Using a Clustering Approach to Investigate Socio-Environmental Inequality in Preterm Birth—A Study Conducted at Fine Spatial Scale in Paris (France), 2018, 15, 1660-4601, 1895, 10.3390/ijerph15091895 | |
2. | Michelle Wong, Alexa Wilkie, Catalina Garzón-Galvis, Galatea King, Luis Olmedo, Esther Bejarano, Humberto Lugo, Dan Meltzer, Daniel Madrigal, Mariana Claustro, Paul English, Community-Engaged Air Monitoring to Build Resilience Near the US-Mexico Border, 2020, 17, 1660-4601, 1092, 10.3390/ijerph17031092 | |
3. | Dustin T. Hill, Michael Petroni, David A. Larsen, Kestutis Bendinskas, Kevin Heffernan, Nader Atallah-Yunes, Patrick J. Parsons, Christopher D. Palmer, James A. MacKenzie, Mary B. Collins, Brooks B. Gump, Linking metal (Pb, Hg, Cd) industrial air pollution risk to blood metal levels and cardiovascular functioning and structure among children in Syracuse, NY, 2021, 193, 00139351, 110557, 10.1016/j.envres.2020.110557 | |
4. | Amanda Pavan, Sue C. Grady, Igor Vojnovic, Racial and ethnic disparities in exposure to risk-screening environmental indicator (RSEI) toxicity-weighted concentrations: Michigan Census Tracts, 2008–2017, 2023, 2190-6483, 10.1007/s13412-023-00816-x | |
5. | Courtney J. Walker, W. Jay Christian, Anna Kucharska-Newton, Steven R. Browning, Iman Al-Saleh, A cross-sectional examination of the early-onset hypertensive disorders of pregnancy and industrial emissions of toxic metals using Kentucky birth records, 2008–2017, 2022, 17, 1932-6203, e0274250, 10.1371/journal.pone.0274250 | |
6. | Sara E. Grineski, Roger Renteria, Timothy W. Collins, Aparna Mangadu, Camden Alexander, Deborah Bilder, Amanda Bakian, Associations between estimates of perinatal industrial pollution exposures and intellectual disability in Utah children, 2022, 836, 00489697, 155630, 10.1016/j.scitotenv.2022.155630 | |
7. | Valentin Simoncic, Séverine Deguen, Christophe Enaux, Stéphanie Vandentorren, Wahida Kihal-Talantikite, A Comprehensive Review on Social Inequalities and Pregnancy Outcome—Identification of Relevant Pathways and Mechanisms, 2022, 19, 1660-4601, 16592, 10.3390/ijerph192416592 |